Voglital 0.3 Tablet
Marketer
Talent India
Salt Composition
Voglibose (0.3mg)
Overview Voglital 0.3 Tablet
Diabetic patients with type 2 diabetes mellitus may benefit from Glyconia 0.3mg tablets to manage postprandial hyperglycemia. This medication is indicated when dietary adjustments and other similar treatments prove insufficient to maintain adequate glycemic control. Glyconia 0.3mg tablets should be administered immediately before meals; dosage and frequency are determined individually by your physician to optimize blood glucose management. Abrupt cessation should be avoided without prior consultation as it could result in dangerously elevated blood sugar levels, potentially causing serious complications such as renal impairment or vision loss. Successful treatment necessitates adherence to a comprehensive program encompassing a balanced diet, regular physical activity, and weight management as directed by your doctor. Regular blood glucose monitoring is essential while using this medication. Commonly reported side effects include abdominal discomfort, such as bloating, pain, loss of appetite, constipation, or diarrhea. Consult your doctor if any adverse effects persist or worsen. While Glyconia 0.3mg tablets do not inherently induce hypoglycemia, concomitant use with other antidiabetic agents, especially insulin or sulfonylureas, elevates the risk. Should hypoglycemic episodes occur, they must be treated with pure glucose; sucrose will be ineffective. Prior to commencing treatment, inform your doctor of any pre-existing liver or kidney conditions. Individuals with inflammatory bowel disease (e.g., ulcerative colitis, Crohn's disease) or peptic ulcers should not use this medication. Pregnant or lactating women should seek medical advice before use. Complete disclosure of all current medications is crucial for safe use. Excessive alcohol consumption should be avoided due to the increased potential for hypoglycemia.
Uses of Voglital 0.3 Tablet
Managing type 2 diabetes
Major Benefits of Voglital 0.3 Tablet:
Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment period. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Voglital 0.3 Tablet should be taken on an empty stomach.
Common Side effects of Voglital 0.3 Tablet:
- Skin rash
- Flatulence
- Abdominal pain
- Diarrhea
How to use Voglital 0.3 Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Voglital 0.3 Tablet whole; avoid chewing, crushing, or breaking it. Administer on an empty stomach.
How Voglital 0.3 Tablet works:
Glicema 0.3mg tablets are an anti-diabetic medication that works by suppressing the activity of intestinal enzymes which digest complex carbohydrates into simpler sugars like glucose. This action helps to control postprandial hyperglycemia.
SAFETY ADVICE
AlcoholUNSAFE
Consuming alcohol while taking Voglital 0.3 Tablets is inadvisable.
PregnancySAFE IF PRESCRIBED
Use of Voglital 0.3 Tablet during pregnancy is typically deemed safe. Preclinical trials in animals revealed minimal or no negative impacts on fetal development; nevertheless, data from human studies remain scarce.
Breast feedingSAFE IF PRESCRIBED
Using Voglital 0.3 Tablet while breastfeeding appears to pose minimal risk. Available human data indicates negligible infant harm.
DrivingSAFE
Driving ability is typically unaffected by Voglital 0.3 Tablet.
KidneyCAUTION
Exercise caution when administering Voglital 0.3 Tablet to individuals with advanced renal impairment. Dosage modification for Voglital 0.3 Tablet might be necessary. Physician consultation is recommended.
LiverCAUTION
Patients with severe hepatic impairment should use Voglital 0.3 Tablet cautiously; dosage modification may be necessary. Physician consultation is advised.
What if you forget to take Voglital 0.3 Tablet :
Omit any missed Voglital 0.3 Tablet dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Voglital 0.3 Tablet
| Label | Value |
|---|---|
| Chemical Type | Valiolamine analog |
| Developing Habits | No. |
| Treatment Category | Diabetes Management |
| Action Class | Alpha-glucosidase inhibitors |






